Literature DB >> 19736478

Analysis of causes of mortality in patients with autosomal dominant polycystic kidney disease: a single center study.

Ebadur Rahman1, Faraz A Niaz, Abdulkareem Al-Suwaida, Shahpar Nahrir, Mohammed Bashir, Habibur Rahman, Durdana Hammad.   

Abstract

This study was aimed at determining the median survival and most frequent causes of death in patients with the autosomal dominant polycystic kidney disease (ADPKD). A retrospective, observational analysis was made on patients registered with a diagnosis of ADPKD, in the computer records of the Sheffield Kidney Institute (SKI), United Kingdom, during the years 1981 to 1999. Data on 363 patients were analyzed from these computer records and further information, if any, was obtained from the patients' clinical notes. During this period, 88 patients died. The median age of the patients who died was 60.5 years, with the youngest being 37 years old and the oldest being 82 years. The major causes of death in this study group were cardiovascular (46.6%), infection (15.9%), central nervous system (CNS) disorders (11.36%), and miscellaneous causes (11.36%). Our study suggests that the major cause of death in patients with ADPKD was cardiovascular followed by infection, of which 42% of the deaths were due to septicemia. CNS causes of death comprised 11.36% of whom 60% had cerebrovascular events including subarachnoid hemorrhage in 20% of the patients. Uremia was the cause of death in only 2.2% of the patients in this series.

Entities:  

Mesh:

Year:  2009        PMID: 19736478

Source DB:  PubMed          Journal:  Saudi J Kidney Dis Transpl        ISSN: 1319-2442


  10 in total

Review 1.  Hypertension in autosomal dominant polycystic kidney disease.

Authors:  Arlene B Chapman; Konrad Stepniakowski; Frederic Rahbari-Oskoui
Journal:  Adv Chronic Kidney Dis       Date:  2010-03       Impact factor: 3.620

2.  Hyperbaric oxygen therapy in a patient with autosomal dominant polycystic kidney disease with a perinephritic abscess.

Authors:  Jorge Vega; Helmuth Goecke; Francisco Manriquez; Carlos Escobar; Max Escobar; Christian Videla; Mario Santamarina; Carlos Echeverria; Francisco Javier Guarda
Journal:  Clin Exp Nephrol       Date:  2010-10-01       Impact factor: 2.801

3.  Early cardiovascular manifestations in children and adolescents with autosomal dominant polycystic kidney disease: a single center study.

Authors:  Vasiliki Karava; Cherine Benzouid; Julien Hogan; Claire Dossier; André Pierre Denjean; Georges Deschênes
Journal:  Pediatr Nephrol       Date:  2018-05-17       Impact factor: 3.714

4.  Assessing Polycystic Kidney Disease in Rodents: Comparison of Robotic 3D Ultrasound and Magnetic Resonance Imaging.

Authors:  Nathan J Beaumont; Heather L Holmes; Adriana V Gregory; Marie E Edwards; Juan D Rojas; Ryan C Gessner; Paul A Dayton; Timothy L Kline; Michael F Romero; Tomasz J Czernuszewicz
Journal:  Kidney360       Date:  2020-10-29

5.  MCP-1 promotes detrimental cardiac physiology, pulmonary edema, and death in the cpk model of polycystic kidney disease.

Authors:  Sally M Salah; James D Meisenheimer; Reena Rao; Jacqueline D Peda; Darren P Wallace; Dawson Foster; Xiaogang Li; Xiaoyan Li; Xia Zhou; Julian A Vallejo; Michael J Wacker; Timothy A Fields; Katherine I Swenson-Fields
Journal:  Am J Physiol Renal Physiol       Date:  2019-05-15

6.  Renal replacement therapy in ADPKD patients: a 25-year survey based on the Catalan registry.

Authors:  Víctor Martínez; Jordi Comas; Emma Arcos; Joan Manel Díaz; Salomé Muray; Juan Cabezuelo; José Ballarín; Elisabet Ars; Roser Torra
Journal:  BMC Nephrol       Date:  2013-09-05       Impact factor: 2.388

7.  Endothelial Dysfunction and Atherosclerosis in Patients With Autosomal Dominant Polycystic Kidney Disease.

Authors:  İskender Ekinci; Mitat Buyukkaba; Ahmet Cinar; Muhammed Tunc; Egemen Cebeci; Meltem Gursu; Rumeyza Kazancioglu
Journal:  Cureus       Date:  2021-02-25

8.  A Systematic Review of Reported Outcomes in ADPKD Studies.

Authors:  Sara S Jdiaa; Nedaa M Husainat; Razan Mansour; Mohamad A Kalot; Kerri McGreal; Fouad T Chebib; Ronald D Perrone; Alan Yu; Reem A Mustafa
Journal:  Kidney Int Rep       Date:  2022-07-05

9.  Hepatointestinal complications in polycystic kidney disease.

Authors:  Shih-Ting Huang; Ya-Wen Chuang; Tung-Min Yu; Cheng-Li Lin; Long-Bin Jeng
Journal:  Oncotarget       Date:  2017-09-15

10.  CD8+ T cells modulate autosomal dominant polycystic kidney disease progression.

Authors:  Emily K Kleczko; Kenneth H Marsh; Logan C Tyler; Seth B Furgeson; Bonnie L Bullock; Christopher J Altmann; Makoto Miyazaki; Berenice Y Gitomer; Peter C Harris; Mary C M Weiser-Evans; Michel B Chonchol; Eric T Clambey; Raphael A Nemenoff; Katharina Hopp
Journal:  Kidney Int       Date:  2018-09-21       Impact factor: 10.612

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.